We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cholesterol Check Recommended for all Young Children

By LabMedica International staff writers
Posted on 04 Dec 2011
New guidelines recommend that all children between the ages of 9 and 11 in the United States should be screened for high cholesterol.

For the widespread screening advocated in the new guidelines, doctors can use a non-HDL cholesterol test that does not require children to fast. More...
Children with abnormal results on this test should be followed up with a fasting lipid profile, according to the guidelines.

The recommendations are a major change from current guidelines that suggest such testing be done only for children who have a family history of heart disease or high blood cholesterol, which is one of the major risk factors for heart disease.

The new guidelines also recommend that children and young adults have their cholesterol levels checked again between the ages of 17 and 21. The purpose of the new guidelines is to improve children's heart health and reduce their future risk of cardiovascular disease. The new guidelines were written by a panel sponsored by the US National Heart, Lung, and Blood Institute (Bethesda, MD, USA) and are endorsed by the American Academy of Pediatrics (AAP; Washington DC, USA).

"The more we learn about heart disease and stroke in adults, the more we know that the process begins in childhood and progresses over time," said Dr. Stephen R. Daniels, head of pediatrics at the University of Colorado School of Medicine (Denver, CO, USA) and chairman of the panel that reviewed the guidelines.

Lifestyle modifications -- such as a healthier diet and more exercise -- would be recommended for most children with high cholesterol. Less than 1 percent of them would qualify for cholesterol-lowering medications such as statins.

The new guidelines were published online November 11, 2011 in the journal Pediatrics and as a supplement to the journal's December print issue.

Related Links:

US National Heart, Lung, and Blood Institute
American Academy of Pediatrics
University of Colorado School of Medicine



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.